Literature DB >> 30545521

Lack of Opioid System in the Antidepressant Actions of Ketamine.

Kai Zhang1, Kenji Hashimoto2.   

Abstract

Entities:  

Year:  2018        PMID: 30545521     DOI: 10.1016/j.biopsych.2018.11.006

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  21 in total

Review 1.  Ketamine: Leading us into the future for development of antidepressants.

Authors:  Flavia R Carreno; Daniel J Lodge; Alan Frazer
Journal:  Behav Brain Res       Date:  2020-02-02       Impact factor: 3.332

Review 2.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

3.  Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?

Authors:  Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

Review 4.  Rodent ketamine depression-related research: Finding patterns in a literature of variability.

Authors:  Andrew J Polis; Paul J Fitzgerald; Pho J Hale; Brendon O Watson
Journal:  Behav Brain Res       Date:  2019-08-13       Impact factor: 3.332

5.  Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.

Authors:  Hildegard A Wulf; Caroline A Browne; Carlos A Zarate; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2022-04-23       Impact factor: 4.530

6.  Response to intravenous racemic ketamine after switch from intranasal (S)-ketamine on symptoms of treatment-resistant depression and post-traumatic stress disorder in Veterans: A retrospective case series.

Authors:  Sean Bentley; Hewa Artin; Eamonn Mehaffey; Fred Liu; Kevin Sojourner; Andrew Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  Pharmacotherapy       Date:  2022-02-24       Impact factor: 4.705

Review 7.  Mechanisms of ketamine and its metabolites as antidepressants.

Authors:  Evan M Hess; Lace M Riggs; Michael Michaelides; Todd D Gould
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

8.  (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation.

Authors:  Jiancheng Zhang; Li Ma; Xiayun Wan; Jiajing Shan; Youge Qu; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2021-07-27       Impact factor: 4.530

9.  Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.

Authors:  Matthew E Klein; Joshua Chandra; Salma Sheriff; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

Review 10.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.